A Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in Diabetes

Launched by XIE MINGXING · Jul 14, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how well the right side of the heart functions in people with Type 2 Diabetes (T2DM) and those who are at risk of developing it (known as prediabetes). Researchers will use a special ultrasound technique called speckle tracking echocardiography to look at the structure and performance of the right heart. They want to understand how the left side of the heart might affect the right side in these patients and see if the function of the right heart can help predict health outcomes for individuals with T2DM.

To participate in this trial, you should have a diagnosis of Type 2 Diabetes according to specific criteria set by the World Health Organization. However, if you have a history of certain heart problems, heart valve issues, or serious lung diseases, you may not be eligible. The trial is not currently recruiting participants, but once it begins, those who qualify will receive detailed information about what to expect during the study, including any tests or follow-ups involved. This research aims to improve our understanding of heart health in people with diabetes, which could lead to better care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • people with T2DM according to the WHO 2006 criteria
• Exclusion Criteria:
• • including history or symptoms of CAD valvular heart disease, rhythm disturbances cardiomyopathy congenital heart disease symptomatic heart failure pulmonary disease